John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOE
1376
DELISTED
Ferro Corporation
FOE
| $1.4M | 0.01% |
111,252
+65,798
| +145% | +$808K |
|
1377
Forum Energy Technologies
FET
$855M
| $1.4M | 0.01% |
3,560
-3,663
| -51% | -$1.33M |
|
|
SIGM
1378
DELISTED
Sigma Designs Inc
SIGM
| $1.39M | 0.01% |
173,651
+48,927
| +39% | +$350K |
|
|
EIGR
1379
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.38M | 0.01% |
162
+112
| +224% | +$979K |
|
1380
Telefônica Brasil
VIV
$18.3B
| $1.38M | 0.01% |
+90,164
| New | +$1.6M |
|
1381
Ryanair
RYAAY
$29.4B
| $1.38M | 0.01% |
50,308
+9,750
| +24% | +$260K |
|
|
LABL
1382
DELISTED
Multi-Color Corp
LABL
| $1.38M | 0.01% |
19,861
+14,190
| +250% | +$902K |
|
|
RALY
1383
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $1.37M | 0.01% |
+87,371
| New | +$1.07M |
|
|
GRP.U
1384
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $1.37M | 0.01% |
+39,000
| New | +$1.39M |
|
1385
CALL
Huntsman Corp
HUN
$1.68B
| $1.37M | 0.01% |
+61,700
| New | +$1.38M |
|
1386
iShares Select U.S. REIT ETF
ICF
$2.12B
| $1.36M | 0.01% |
27,000
-1,400
| -5% | -$71.4K |
|
1387
CALL
Air Products & Chemicals
APD
$68.2B
| $1.36M | 0.01% |
+9,729
| New | +$1.35M |
|
1388
Resources Connection
RGP
$147M
| $1.36M | 0.01% |
77,817
+25,724
| +49% | +$443K |
|
|
GPX
1389
DELISTED
GP Strategies Corp.
GPX
| $1.36M | 0.01% |
36,799
+12,942
| +54% | +$446K |
|
1390
CALL
Helmerich & Payne
HP
$4.25B
| $1.36M | 0.01% |
+20,000
| New | +$1.31M |
|
1391
Entergy
ETR
$49.4B
| $1.36M | 0.01% |
+35,112
| New | +$1.44M |
|
1392
PUT
McKesson
MCK
$102B
| $1.36M | 0.01% |
+6,000
| New | +$1.33M |
|
|
SJT
1393
San Juan Basin Royalty Trust
SJT
$130M
| $1.35M | 0.01% |
113,169
-6,940
| -6% | -$96K |
|
1394
IDT Corp
IDT
$1.7B
| $1.35M | 0.01% |
107,892
-22,512
| -17% | -$327K |
|
|
FLTX
1395
DELISTED
Fleetmatics Group PLC
FLTX
| $1.35M | 0.01% |
+30,100
| New | +$1.19M |
|
|
1396
CALL
AbbVie
ABBV
$467B
| $1.35M | 0.01% |
+23,000
| New | +$1.39M |
|
1397
CALL
Vornado Realty Trust
VNO
$7.26B
| $1.34M | 0.01% |
+14,844
| New | +$1.33M |
|
|
MTOR
1398
DELISTED
MERITOR, Inc.
MTOR
| $1.34M | 0.01% |
+106,509
| New | +$1.48M |
|
|
FGL
1399
DELISTED
Fidelity & Guaranty Life
FGL
| $1.34M | 0.01% |
63,358
+15,615
| +33% | +$340K |
|
1400
PUT
CVS Health
CVS
$120B
| $1.34M | 0.01% |
+13,000
| New | +$1.32M |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.